Warren Chan

The Chan Research Group aims to develop and applying nanomaterials for improving the diagnosis of cancer and infectious diseases, two of the leading causes of death in the world. We utilize the distinct properties associated with nanomaterials (e.g., quantum dots, metal nanoparticles) to engineer contrast agents and delivery vehicles for targeting disease-relevant molecules, cells, organs, and tissues both in vitro and in vivo. Researchers in the lab acquire a broad range of skills, including nanomaterial design, polymer synthesis, cell culturing, and growing animal tumor models.